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A primary feature of drug addiction is the compulsive use despite negative consequences.
A general consensus is emerging on the capacity of addictive substances to co-opt synaptic
transmission and synaptic plasticity in brain circuitswhich are involved in reinforcement and
reward processing. A current hypothesis is that drug-driven neuroadaptations during learn-
ing andmemory processes divert the functions of these brain circuits, eventually leading to
addictive behaviors. Metabotropic glutamate receptors (mGluRs) not only lead to long-term
modulation of synaptic transmission but they have been implicated in drug-evoked synaptic
plasticity and drug-seeking behaviors in two importantways.mGluR-dependentmodulation
of synaptic transmission is impaired by drug experience but interestingly their activation has
been indicated as a strategy to restore baseline transmission after drug-evoked synaptic
plasticity. Here we focus on the cellular mechanisms underlying mGluR-dependent long-
term changes of excitatory synapses, and review results implicating these receptors in
drug-evoked synaptic plasticity.
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INTRODUCTION
Significant evidence is converging to the idea that glutamatergic
transmission plays a pivotal role in addictive-like behaviors (Kali-
vas, 2004; Gass and Olive, 2008). Studies employing rodent models
suggest the use of metabotropic glutamate receptor (mGluR)
modulators as a therapeutic strategy in treating drug addiction
(Spooren et al., 2003). Importantly, the potential use of mGluR lig-
ands lies in understanding the function of mGluRs at synapses in
the central nervous system. These receptors are G-protein-coupled
and classified in three groups according to their sequence homol-
ogy (Pin and Duvoisin, 1995). However, drug development and
fundamental research have focused their attention on Group I
(mGluR-I) and Group II mGluRs (mGluR-II) as potential thera-
peutic targets. For this reason, in the present review we will focus
on the properties of mGluRs and on the implication of mGluR-
I- and mGluR-II-dependent synaptic plasticity in the context of
drug-seeking.
GROUP I AND II mGLuRs
mGluR-I are postsynaptically enriched at glutamatergic synapses.
They couple to G-proteins of the Gq/G11 family and acti-
vate phospholipase Cβ leading to the hydrolysis of phos-
photinositides followed by the generation of inositol 1,4,5-
trisphosphate and diacylglycerol. This canonical signaling cascade
triggers calcium mobilization and activation of a broad range of
downstream effectors, including protein kinase C (PKC) path-
way, the mitogen-activated protein kinase/extracellular receptor
kinase pathway, and the mammalian target of rapamycin/p70
S6 kinase pathway (Hou and Klann, 2004; Page et al., 2006).
Activation of these secondary signaling cascades by mGluR-
I modulates both ion channel function and endocannabinoid
(eCB) synthesis (Kammermeier et al., 2000; Galante and Diana,
2004).
mGluRs-I comprises the mGluR1 and mGluR5 which are
broadly expressed in the brain. Subcellular electron microscopy
localized these receptors on the postsynaptic membrane in the
perisynaptic zone (Lujan et al., 1997) where they regulate both
inhibitory and excitatory synaptic transmission. Although both
receptors are Gq-coupled, their signaling proprieties are different,
suggesting distinct neuronal function (Choi et al., 2011).
mGluR-II (mGluR2 and mGluR3), are coupled to Gi/o proteins
that inhibit adenylate cyclase and prevent the formation of cyclic
adenosine 3′5′-monophosphate (cAMP). These receptors are pre-
dominantly expressed presynaptically (Niswender and Conn,
2010) and their activation can decrease neurotransmitter release
via a cascade of events that engage voltage-gated calcium channels
as well as SNAP-25-dependent mechanisms (Anwyl, 1999; Cart-
mell and Schoepp, 2000, Robbe et al., 2002a; Upreti et al., 2012).
The activation of these two subfamilies of mGluRs at exci-
tatory synapses modulates the strength of synaptic transmission
by inducing both long-term potentiation (LTP) and long-term
depression (LTD) in various brain regions (Lüscher and Huber,
2010). In particular mGluR-dependent LTD has been extensively
studied at various synapses and multiple induction mechanisms
have been described to modulate the synaptic transmission in
normal function as well as in diseases (Bellone et al., 2008).
SYNAPTIC PLASTICITY AND DRUG-SEEKING
Addictive drugs target the mesocorticolimbic dopamine (DA)
circuit (Lüscher and Ungless, 2006) that originates in the ven-
tral tegmental area (VTA), where DA neurons project mainly to
the nucleus accumbens (NAc) and prefrontal cortex (PFC). A
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common feature of addictive drugs is their ability to trigger an
increase in extracellular DA levels in VTA and projecting areas,
and to cause adaptations both at glutamatergic and GABAergic
synapses (Kauer and Malenka, 2007). These drug-evoked synaptic
adaptations are, in the long run, able to reorganize the neural
circuits, and may represent a fundamental cellular mechanism
leading to addictive behavior (Lüscher and Malenka, 2011).
In the specific case of cocaine, it has been shown that acute and
chronic drug exposure increases the ratio of AMPA and NMDA
receptor mediated currents in different brain areas, suggesting an
increase in synaptic efficacy at excitatory inputs (Thomas et al.,
2001; Ungless et al., 2001, Dumont et al., 2005; Bellone and
Lüscher, 2006).
Along with changes in AMPA and NMDA receptor mediated
transmission, drug exposure alters mGluR-dependent synaptic
plasticity. mGluRs-I and mGluRs-II have been implicated in these
phenomena, as well as in drug-evoked behavioral adaptations
(Olive, 2009) (Figure 1). However, a causal link between the
synaptic and the behavioral observations remains elusive.
DRUG EXPOSURE IMPAIRS mGLuR-DEPENDENT PLASTICITY
Addictive drugs alter mGluR-dependent synaptic plasticity in
brain regions related to the mesolimbic system. In the NAc, the
pharmacological activation of mGluRs-I by the agonist (S)-3,5-
dihydroxyphenylglycine (DHPG) promotes release of eCBs and
reduces glutamate release via the activation of cannabinoid 1
(CB1) receptors, leading to a presynaptic form of LTD (Fourgeaud
et al., 2004). A single in vivo exposure to cocaine or delta-
tetrahydrocannabinol transiently impairs this form of mGluR-
LTD (Fourgeaud et al., 2004; Mato et al., 2004) via the reduction
of mGluR5 expression and the dysfunction of CB1Rs (Fourgeaud
et al., 2004; Mato et al., 2004). The intermediate role of D1 recep-
tor signaling seems to play a fundamental role in this cascade. The
abolishment of this form of plasticity in the NAc may represent
a mechanism to counteract the decrease in glutamatergic activity
observed after cocaine exposure (Pierce et al., 1996). However, the
overall cellular mechanism underlying cocaine-evoked reduction
of mGluR5 protein and signaling remains unclear. Importantly,
interplay between mGluRs and eCB may exist. As recently shown, a
single cocaine injection impairs eCB-LTD in D2-containing MSNs
in the NAc suggesting that cocaine may disrupt eCB-dependent
synaptic plasticity via alterations in mGluR-signaling (Grueter
et al., 2012).
An important role of mGluR5 has been as well established in
the bed nucleus of stria terminalis (BNST), an integrative center
implicated in stress and rewarding responses (Jalabert et al., 2009).
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FIGURE 1 |The role of mGluR-LTD during drug-seeking. mGluR-I
are mainly located at the postsynaptic membrane, while mGluR-II are
mostly presynaptic. While mGluR-I-LTD has been extensively
described as postsynaptic and occurring through the removal of
AMPARs, mGluR-II LTD expression is presynaptic, involving a
decrease in neurotransmitter release. Acute drug exposure or
withdrawal abolishes mGluR-LTD in various structures including the
BNST and the NAc (Top). On the other hand forms of mGluR-LTD are
able to rescue drug-evoked synaptic plasticity and behavioral
adaptations (Bottom).
Frontiers in Pharmacology | Neuropharmacology August 2012 | Volume 3 | Article 159 | 2
Bellone and Mameli mGluRs and drug abuse
While a single cocaine injection does not alter mGluR-I-LTD in this
region, chronic drug treatment impairs this form of plasticity 24 h
after the last injection (Grueter et al., 2006). Indeed, decreasing
the function in vivo of mGluR5 by using the specific antagonist
MPEP, prevented cocaine-induced abolishment of the mGluR-I-
LTD (Grueter et al., 2008). Although the cascade of events has been
partially characterized, it is so far unclear whether cocaine prevents
the mGluR-I-LTD or whether it engages mGluR-dependent signal-
ing occluding the synaptic plasticity. Therefore the mechanisms by
which drug experience impairs mGluR-I-LTD in the BNST remain
in part elusive.
The cellular adaptations described above occur days after drug
exposure in virtually all treated animals and therefore they could
represent an early mechanism for priming addictive behaviors. A
critical step in the development of the disease is the shift from a
recreational and controlled drug use to a compulsive drug taking
despite negative consequences (American Psychiatric Association,
1994). Addiction can be modeled in animals, and rodent models
have been established reflecting the human conditions. Indeed,
only a restricted number of animals fulfill the hallmarks of drug
addiction (“addict” vs. “non-addict”) suggested by the Diagnostic
and Statistical Manual of Mental Disorders (Deroche-Gamonet
et al., 2004). This animal model has been recently employed
to identify the biological traits of individual vulnerability to
addiction.
Excitatory synapses onto MSN neurons of the NAc undergo
two different forms of LTD: one is induced by mGluR-II activa-
tion and expressed presynaptically while the other is induced by
NMDAR activation and expressed postsynaptically. While in“non-
addict” and “addict” animals the mGluR-II-LTD is unaffected,
NMDAR-LTD is abolished in “addict” rats (Kasanetz et al., 2010).
Interestingly, rats with a short history of cocaine seeking showed
impaired NMDA-LTD, suggesting that while in “non-addict” rats
synaptic function goes back to baseline, in“addict”rats the NMDA-
LTD remains impaired. This suggests that this “anaplasticity,” the
inability to rescue normal baseline synaptic transmission, may
represent a cellular locus for the shift to compulsive drug use
(Kasanetz et al., 2010).
The glutamatergic afferents so far described remain elusive,
however there are reasons to believe that they might be arising
from cortical brain areas. Indeed, modulation of cortical inputs
onto MSNs rescues cocaine-evoked synaptic and behavioral adap-
tations (Pascoli et al., 2012). Furthermore cortical brain areas are
important in the control of drug intake (Kalivas et al., 2005). This
evidence raises the hypothesis that alteration in mGluR-dependent
synaptic plasticity can as well occur within the PFC. In a recent
study, cocaine self-administration, in both “addict” and “non-
addict” rats abolished the eCB-LTD in the PFC (Lafourcade et al.,
2007). On the other hand, a decrease in mGluR2/3 protein lev-
els in “addict” animals impaired the induction of mGluR-II-LTD
(Kasanetz et al., 2012). The specific impairment of mGluR-II-LTD
in this animal model provides important insight for the role of
mGluRs during the development of addiction. The observation
in NAc and PFC supports a scenario in which the impairment of
long-term synaptic plasticity in “addict” animals may represent a
substrate for transition to addiction in interconnected structures
of the mesocorticolimbic circuit.
As described above, many evidences described the impairment
of mGluR-LTD in various regions of the mesocorticolimbic sys-
tem at different time points of drug use. The interpretation of the
data is however not trivial. How mGluR-LTD impairment may
account for the development of complex behavior such as com-
pulsive drug use? Linking “anaplasticity” with lack of flexibility in
controlling drug use over time, while intriguing, may not repre-
sent the only explanation. Future studies would need to assess the
cellular, molecular, genetic adaptations that occur in parallel with
the impairment of mGluR-LTD during the development of drug
addiction.
RESCUE OF COCAINE-EVOKED PLASTICITY BY mGLuRs
While many different forms of drug-evoked synaptic plasticity
have been described in the mesolimbic system, several observa-
tions point to the capacity of mGluRs to reverse cocaine-evoked
adaptations both in the VTA and in the NAc.
Drug-evoked synaptic plasticity occurs in the VTA within a
few hours after drug exposure, it persists for about a week, and
it is permissive for further adaptations in the NAc, suggesting
a hierarchy in the drug-evoked synaptic plasticity (Argilli et al.,
2008; Mameli et al., 2009). Three different parameters of synaptic
transmission change early on after drug exposure. First, a single
injection with cocaine, morphine, ethanol or nicotine increases
the AMPA to NMDA ratio at excitatory synapses onto DA neurons
(Ungless et al., 2001; Saal et al., 2003). This occurs concomitantly
with a change in the subunit composition of AMPAR-mediated
responses (Bellone and Lüscher, 2006). Indeed, the current-voltage
relationship of AMPA receptor responses shows an inward rectifi-
cation suggesting the insertion of GluA2-lacking calcium perme-
able AMPA receptors (CP-AMPARs) after drug exposure. The use
of two-photon laser photolysis of caged glutamate further iden-
tified a decrease in function of NMDARs and altogether these
synaptic changes contribute to invert learning rules (Mameli et al.,
2011).
Interestingly the CP-AMPARs can be removed from the
synapses both in vitro and in vivo. In slices from mice treated with
a single cocaine injection, the agonist of mGluR-I, DHPG, induces
a form of LTD that is expressed by the removal of CP-AMPARs
and the insertion of calcium impermeable GluA2-containing (CI)-
AMPARs (Bellone and Lüscher, 2006). This suggests that drug
exposure and in turn the presence of CP-AMPARs reveals a previ-
ously absent mGluR-LTD at these synapses. The mGluR-I-driven
switch in AMPAR subunit composition restores baseline transmis-
sion and it relies on thedenovo synthesis of GluA2 protein (Mameli
et al., 2007). Since NMDAR function also changes after drug expo-
sure, it will be important in the future to investigate whether the
activation of mGluR-I also rescues transmission of NMDARs.
Reversal of cocaine-induced synaptic plasticity occurs in vivo as
well. Injection of a positive allosteric modulator of mGluR1 is able
to remove CP-AMPARs, restoring basal transmission, and prevent-
ing more widespread changes downstream to the NAc (Bellone
and Lüscher, 2006; Mameli et al., 2009). These observations led
to the hypothesis that mGluR-I modulation represents a pharma-
cological tool to revert early drug-evoked plastic changes. Three
major questions arise from these studies: (i) how does cocaine
alter mGluR-signaling pathway? (ii) does the mGluR-I-LTD after
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insertion of CP-AMPARs occurs in other brain structures? and
(iii) what is the behavioral implication of these early synaptic
adaptations and its rescue by mGluR-I activation?
Susceptibility to relapse is a core component in the addic-
tion process. Relapse can be modeled in rodents by exposing
animals to drug-related cues after long withdrawal periods fol-
lowing self-administration, a paradigm termed incubation of
craving (Lu et al., 2004). In acute slices containing NAc, synap-
tic GluA1 protein increases after 45 days of withdrawal following
cocaine self-administration. These receptors were functional at
synapses as indicated by the presence of inwardly rectifying AMPA-
mediated currents and by the sensitivity to specific CP-AMPARs
open-channel blockers (Conrad et al., 2008; Mameli et al., 2009,
McCutcheon et al., 2011b). In conclusion, the switch from CI-
AMPARs to CP-AMPARs at excitatory synapses onto MSN neu-
rons of the NAc, may represent a cellular substrate for cocaine
seeking. In addition to these observations, it has been recently
shown that a new form of mGluR-I-LTD occurs after cue-induced
cocaine craving in the NAc. While the activation of mGluR5 no
longer induces the eCB-mediated LTD that is generally observed
in drug naïve animals, mGluR1 activation induces a form of LTD
that reverses the cocaine-induced accumulation of CP-AMPARs,
restoring the initial AMPA-mediated transmission (McCutcheon
et al., 2011a). This form of plasticity in the NAc depends on
calcium/PKC signaling and therefore shows many common fea-
tures with the mGluR-LTD described in the VTA (Bellone and
Lüscher, 2005). Two important points remain still elusive: how
does mGluR-signaling change upon cocaine experience? Is the
mGluR-LTD a general feature of D1- and D2-expressing neurons
in the NAc? These results together with future studies may provide
insights to the appealing hypothesis that mGluR1s represent a gate
controlling the levels of CP-AMPARs vs. CI-AMPARs. Indeed, a
single drug exposure only transiently drives CP-AMPAR insertion
in DA neurons of the VTA. In this case mGluR tone allows the
system to recover baseline transmission in about a week. However,
chronic cocaine treatment or self-administration overrides this
key function such that endogenous activation of mGluR1 is not
enough to restore basal transmission. This mediates more persis-
tent changes in theVTA and the occurrence of synaptic adaptations
in the NAc. Pharmacological boosting of mGluR1 function enables
mGluR-I-LTD and in turns rescues baseline synaptic transmission
in both VTA and NAc, suggesting a potential therapeutic impact
at the behavioral level.
A further important role of mGluR-I-mediated plasticity has
been recently shown at the developmental stage. The postnatal
development of glutamatergic transmission requires mGluR1 acti-
vation in the VTA switching CP-AMPARs to CI-AMPARs (Bellone
et al., 2011). In utero cocaine exposure delays the synaptic matura-
tion of both AMPAR- and NMDAR-mediated transmission in the
offspring such that excitatory synapses onto DA neurons show CP-
AMPARs and GluN2B containing NMDARs beyond P14. Interest-
ingly, the activation of mGluR1 in vivo by an allosteric modulator
rescues the synaptic impairment induced by cocaine by inserting
CI-AMPARs and GluN2A NMDARs. These observations led to
the conclusion that in offspring from cocaine-exposed mothers,
mGluR1 becomes inefficient to drive the postnatal maturation.
The role of rescuing drug-evoked synaptic abnormalities has
also been proposed for mGluR-II. Repeated cocaine exposure
alters the function of mGlu2/3 receptors and impairs the
mGluR2/3-dependent plasticity both in the PFC and NAc (Xi et al.,
2002; Huang et al., 2007, Xie and Steketee, 2008). As a consequence,
both LTP and LTD are impaired in rats extinguished from cocaine
self-administration for at least 3 weeks (Moussawi et al., 2009).
Therefore, restoring the tone of mGluR2/3 would be able to res-
cue the ability of the excitatory synapses to induce LTP as well
drug-seeking behaviors. For this purpose, N -acetylcysteine has
been used as an indirect agonist of mGluR2/3 to restore glutamate
homeostasis (Baker et al., 2003; Zhou and Kalivas, 2008). Acute
administration of N -acetylcysteine has been shown to prevent
drug-seeking and to reverse synaptic transmission in NAc. Inter-
estingly the activation of different mGluRs has opposite effects;
while the direct pharmacological activation of mGluR2/3 prevents
the relapse in the reinstatement model of cocaine, the activation
of mGluR5 does not inhibit the cocaine seeking behaviors. On
the contrary, block of mGluR5 prevents cocaine reinstatement for
drug-seeking, suggesting dissociation between synaptic plasticity,
and behavioral models. These somehow contrasting data require
a further investment in the understanding of the roles of different
mGluR subfamilies in modulating of drug-seeking behaviors.
CONCLUDING REMARKS
During the past decade our understanding of mGluR function
has led to the development of a wide range of pharmacological
and genetic tools that contributed to the discovery of the role of
mGluRs in brain function. Many behavioral evidences suggested
an important role of mGluR-signaling in cocaine reinforcement
as well as cocaine extinction and reinstatement (Kumaresan et al.,
2009; Wang et al., 2012). We focused here on mGluR-dependent
plasticity, a key player in learning processes as well as in disorders
of the nervous system. Much experimental evidence highlights the
role of mGluR-LTD in mediating early (acute drug exposure) and
late processes (chronic and self-administration paradigms), dur-
ing the etiology of addictive behaviors. A big challenge in the field is
to directly link specific synaptic modification to specific behaviors
and, while a large effort has focused on the drug-evoked changes
in mGluR-LTD after acute exposure to addictive substances, much
work is still required to better probe the importance of mGluR-
LTD during the late phase of the disease. Future studies will need
to investigate how changes in synaptic plasticity can lead to drug
addiction. A feature in the etiology of addictive behaviors is the
recruitment in a hierarchical fashion from ventral (VTA, sub-
stantia nigra, NAc) to dorsal (dorsal striatum) brain structures
(Belin and Everitt, 2008; Mameli et al., 2009). mGluRs are largely
expressed in the striatum, a region implicated in goal-directed
behaviors, however the links between mGluR-dependent plasticity
in this region and drug-seeking remain yet unknown.
Another important component of mGluR-I activation in the
midbrain and in the striatum is the synthesis of eCB, which medi-
ate often short- as well as long-term presynaptic forms of plasticity.
Drug exposure generally leads to an impairment eCB-LTD at both
inhibitory and excitatory synapses, an effect that may contribute
to drug-evoked behavioral adaptations. Further characterization
of the interactions mGluRs, eCB, and synaptic plasticity in the
context of drug-seeking would be certainly important to probe
the potential benefits of compounds targeting CBRs and eCB
signaling.
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Finally determining the behavioral consequences of mGluR-
LTD-dependent rescue of plasticity and understanding whether
inter-individual vulnerability to addiction lies in genetic,
environmental-linked variation in mGluR function represents the
major breakthroughs for the development of therapeutic strategies
of addictive behaviors.
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